reglab/statecodes huggingface dataset:
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 15 - Anatomical Parts › Subchapter IV - Organ and Tissue Donor Registry › § 7–1561.03. Sources of Registry information

§ 7–1561.03. Sources of Registry information.
Repealed.
(July 25, 2006, D.C. Law 16-146, § 4, 53 DCR 4407; Apr. 15, 2008, D.C. Law 17-145, § 30(f), 55 DCR 2532.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 15 - Anatomical Parts › Subchapter IV - Organ and Tissue Donor Registry › § 7–1561.04. Department of Motor Vehicles transfer of information requirements

§ 7–1561.04. Department of Motor Vehicles transfer of information requirements.
Repealed.
(July 25, 2006, D.C. Law 16-146, § 5, 53 DCR 4407; Apr. 15, 2008, D.C. Law 17-145, § 30(f), 55 DCR 2532.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 15 - Anatomical Parts › Subchapter IV - Organ and Tissue Donor Registry › § 7–1561.05. Donor status not dependent on being listed in Registry

§ 7–1561.05. Donor status not dependent on being listed in Registry.
Repealed.
(July 25, 2006, D.C. Law 16-146, § 6, 53 DCR 4407; Apr. 15, 2008, D.C. Law 17-145, § 30(f), 55 DCR 2532.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 15 - Anatomical Parts › Subchapter IV - Organ and Tissue Donor Registry › § 7–1561.06. Rulemaking

§ 7–1561.06. Rulemaking.
Repealed.
(July 25, 2006, D.C. Law 16-146, § 7, 53 DCR 4407; Apr. 15, 2008, D.C. Law 17-145, § 30(f), 55 DCR 2532.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter I - General › § 7–1601. Definitions

§ 7–1601. Definitions.
For the purpose of this subchapter, the term:
(1) “AIDS” means acquired immune deficiency syndrome or any AIDS-related condition.
(2) “Council” means the Council of the District of Columbia.
(3) “Director” means the Director of the Department of Health, established by Reorganization Plan No. 4 of 1966, effective July 17, 1996.
(3A) “Domestic partnership” shall have the same meaning as provided in § 32-701(4).
(4) “Families” means persons who are related by blood, legal custody, marriage, domestic partnership, having a child in common, or who share or have shared for at least 1 year a mutual residence and who maintain or have maintained an intimate relationship rendering the application of this subchapter appropriate.
(5) “Mayor” means the Mayor of the District of Columbia.
(June 10, 1986, D.C. Law 6-121, § 2, 33 DCR 2451; Sept. 12, 2008, D.C. Law 17-231, § 18, 55 DCR 6758; Mar. 25, 2009, D.C. Law 17-353, § 130(a), 56 DCR 1117.)
Prior Codifications
1981 Ed., § 6-2801.
Effect of Amendments
D.C. Law 17-231 added par. (3A); and, in par. (4), substituted “marriage, domestic partnership,” for “marriage,”.
D.C. Law 17-353, in par. (3), substituted “Department of Health, established by Reorganization Plan No. 4 of 1966, effective July 17, 1996” for “Department of Human Services, established by Reorganization Plan No. 2 of 1979, approved February 21, 1980”.
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter I - General › § 7–1602. Comprehensive AIDS Health-Care Response Plan

§ 7–1602. Comprehensive AIDS Health-Care Response Plan.
(a) Within 6 months of December 30, 1985, the Mayor shall develop and present to the Council for its review and comment a comprehensive AIDS Health-Care Response Plan for the District of Columbia. The plan shall include, but not be limited to, the development of short-term and long-term goals and schemes for administrative coordination by District government agencies, educational programs, prevention methods and programs, a compilation of private sector services available to AIDS patients, medical research and information gathering, outpatient and inpatient health-care services delivery, social services delivery, exploration of the feasibility of establishing a separate compensation rate for District employees working in the health-care treatment facility or facilities contemplated in § 7-1603, housing, and identifying other general services needs.
(b) The Mayor shall update annually the comprehensive plan mandated by subsection (a) of this section.
(June 10, 1986, D.C. Law 6-121, § 3, 33 DCR 2451.)
Prior Codifications
1981 Ed., § 6-2802.
Section References
This section is referenced in § 7-1603 and § 7-1604.
Editor's Notes
Mayor authorized to make AIDS grants: Section 2 of D.C. Law 10-165 provided that the Mayor shall have the authority to make grants, with appropriated funding, for HIV/AIDS related services pursuant to the regulations contained in Chapter 80 of Title 22 of the District of Columbia Municipal Regulations governing the administration of public health grants by the Department of Human Services.
Establishment and Appointments—Mayor’s Advisory Committee on HIV/AIDS, see Mayor’s Order 2003-31, March 12, 2003 ( 50 DCR 2386).
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter I - General › § 7–1603. Residential health-care facility

§ 7–1603. Residential health-care facility.
(a) In preparing the comprehensive plan mandated in § 7-1602, the Mayor shall investigate the need for a residential health-care facility or facilities which shall provide a program of medical, nursing, counseling, palliative, social, recreational, and supportive services to AIDS patients and their families.
(b) If, following an investigation, the Mayor identifies a need for a residential health-care facility or facilities in the District of Columbia, the Mayor shall establish the facility or facilities.
(c) In order to establish the facility or facilities, the Mayor may acquire, by purchase, rehabilitation, condemnation, rental, or otherwise, a building or buildings suitable for use as a residential health-care facility or facilities, including furniture, medical equipment, and other necessary accessories.
(d) The Mayor may enter into contractual arrangements with any agency or organization qualified to provide the services enumerated in subsection (a) of this section.
(June 10, 1986, D.C. Law 6-121, § 4, 33 DCR 2451.)
Prior Codifications
1981 Ed., § 6-2803.
Section References
This section is referenced in § 7-1602.
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter I - General › § 7–1604. AIDS Program Coordination Office

§ 7–1604. AIDS Program Coordination Office.
(a) The Mayor shall establish, within the Department of Health, an AIDS Program Coordination Office.
(b) The AIDS Program Coordination Office shall be supervised by the AIDS Program Coordination Officer who shall, at the direction of the Director of the Department of Health, be responsible for the coordination of and serving as the point of contact for the District of Columbia’s comprehensive AIDS Health-Care Response Plan established by § 7-1602.
(c) The AIDS Program Coordination Officer shall:
(1) Analyze medical data, reports, and information to determine the effectiveness with which the AIDS program is meeting the needs of the residents of the District of Columbia;
(2) Coordinate and assist in the development of grant proposals to obtain funds from both the federal government and the private sector for AIDS and AIDS-related activities;
(3) Develop and coordinate, with other agencies of the District government, a program of health-care services delivery and other supportive services for persons with AIDS living at home;
(4) Disseminate information on AIDS to the public;
(5) Assist officials from the federal government, community groups, nursing homes, hospitals, and others in the coordination of AIDS plans, programs, and services delivery for persons with AIDS living in the District of Columbia;
(6) Serve as the liaison officer for the District’s AIDS program to other District government agencies and monitor their compliance with the District’s comprehensive AIDS program;
(7) Conduct community outreach and education programs; and
(8) Perform other duties appropriate to accomplish the objectives of this subchapter.
(June 10, 1986, D.C. Law 6-121, § 5, 33 DCR 2451; Mar. 2, 2007, D.C. Law 16-191, § 7, 53 DCR 6794; Mar. 25, 2009, D.C. Law 17-353, § 130(b), 56 DCR 1117.)
Prior Codifications
1981 Ed., § 6-2804.
Effect of Amendments
D.C. Law 16-191 substituted “Health” for “Human Services”.
D.C. Law 17-353 validated a previously made technical correction in subsec. (a).
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter I - General › § 7–1605. Confidentiality of medical records and information

§ 7–1605. Confidentiality of medical records and information.
The Director shall use the records incident to a case of HIV infection or AIDS reported under this subchapter for statistical and public-health purposes only. Identifying information contained in these records, as well as all identifying information obtained, collected, or created by the Department of Health ("Department") shall be disclosed by the Director only when essential to safeguard the physical health of others. No person shall otherwise disclose such identifying information unless the person about whom the information pertains gives his or her prior written permission. All identifying information obtained, collected, or created by the Department under this subchapter shall not be discoverable or admissible as evidence in a civil or criminal action unless the person about whom the information pertains gives his or her prior written permission.
(June 10, 1986, D.C. Law 6-121, § 6, 33 DCR 2451; Dec. 4, 2010, D.C. Law 18-273, § 206, 57 DCR 7171; Sept. 21, 2022, D.C. Law 24-170, § 2, 69 DCR 009207.)
Prior Codifications
1981 Ed., § 6-2805.
Effect of Amendments
D.C. Law 18-273 rewrote the section, which had read as follows: “The provisions of the Preventive Health Services Amendments Act of 1985 (D.C. Law 6-83), pertaining to the confidentiality of medical records and information on persons with AIDS, shall be applicable to this chapter.”
Emergency Legislation
For temporary (90 day) amendment of section, see § 206 of Data-Sharing and Information Coordination Emergency Amendment Act of 2010 (D.C. Act 18-530, August 6, 2010, 57 DCR 8099).
For temporary (90 day) amendment of section, see § 206 of Data-Sharing and Information Coordination Congressional Review Emergency Amendment Act of 2010 (D.C. Act 18-582, October 20, 2010, 57 DCR 10118).
Delegation of Authority
Delegation of authority pursuant to Law 6-121, see Mayor’s Order 86-171, September 30, 1986.
Delegation of authority pursuant to D.C. Law 6-121, the “AIDS Health-Care Response Act of 1986”, see Mayor’s Order 2000-55, March 29, 2000 ( 47 DCR 4735).
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter I - General › § 7–1606. Rules

§ 7–1606. Rules.
The Mayor may issue rules necessary to implement this subchapter pursuant to subchapter I of Chapter 5 of Title 2.
(June 10, 1986, D.C. Law 6-121, § 7, 33 DCR 2451.)
Prior Codifications
1981 Ed., § 6-2806.
Emergency Legislation
For temporary addition of chapter, see § 2-4 of the HIV Testing of Certain Criminal Offenders Emergency Act of 1992 (D.C. Act 9-318, November 24, 1992, 39 DCR 9016).
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter II - Effi Slaughter Barry HIV/AIDS Initiative › § 7–1611. Findings

§ 7–1611. Findings.
The Council finds that:
(1) Effi Slaughter Barry, a former First Lady of the District of Columbia, was among the first public figures in the District to focus attention on the growing health problem of HIV/AIDS;
(2) Effi Slaughter Barry, a trained and experienced health professional, was a champion of HIV/AIDS prevention and wellness and was particularly concerned with the dearth of services East of the River;
(3) At the time of her death, September 6, 2007, Effi Slaughter Barry, was Director of Special Projects in the Office of the Director of the Department of Health, providing direct leadership to the East of the River HIV/AIDS Initiative; and
(4) In light of Effi Slaughter Barry’s commitment to health and, in particular, to helping residents of the District of Columbia combat HIV/AIDS, it is fitting that the East of the River HIV/AIDS Capacity Building Initiative should be known as the Effi Slaughter Barry HIV/AIDS Initiative.
(Mar. 20, 2008, D.C. Law 17-117, § 2, 55 DCR 1282.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter II - Effi Slaughter Barry HIV/AIDS Initiative › § 7–1612. Designation of the Effi Slaughter Barry HIV/AIDS Initiative

§ 7–1612. Designation of the Effi Slaughter Barry HIV/AIDS Initiative.
The East of the River HIV/AIDS Capacity Building Initiative administered by the Department of Health shall be known as the Effi Slaughter Barry HIV/AIDS Initiative (“initiative”).
(Mar. 20, 2008, D.C. Law 17-117, § 3, 55 DCR 1282.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter II - Effi Slaughter Barry HIV/AIDS Initiative › § 7–1613. Purpose

§ 7–1613. Purpose.
(a) The initiative shall provide technical and financial assistance to selected community HIV/AIDS service providers located east of the Anacostia river to support the:
(1) Implementation or expansion of HIV/AIDS prevention and support programs;
(2) Development of accurate performance measurement capabilities; and
(3) Promotion of revenue diversity.
(b) Assistance to selected community HIV/AIDS service providers shall be provided for up to 2 years.
(Mar. 20, 2008, D.C. Law 17-117, § 4, 55 DCR 1282; Mar. 3, 2010, D.C. Law 18-111, § 5021(a), 57 DCR 181.)
Effect of Amendments
D.C. Law 18-111 rewrote the section, which had read as follows: “The initiative shall provide technical and financial assistance to selected community HIV/AIDS service providers as part of a 2-year program designed to build operational capacities, improve HIV/AIDS service delivery, enable accurate performance measurement, and increase revenue diversity.”
Emergency Legislation
For temporary (90 day) amendment of section, see § 5021(a) of Fiscal Year 2010 Budget Support Second Emergency Act of 2009 (D.C. Act 18-207, October 15, 2009, 56 DCR 8234).
For temporary (90 day) amendment of section, see § 5021(a) of Fiscal Year Budget Support Congressional Review Emergency Amendment Act of 2009 (D.C. Act 18-260, January 4, 2010, 57 DCR 345).
Short Title
Short title: Section 5020 of D.C. Law 18-111 provided that subtitle C of title V of the act may be cited as the “Effi Slaughter Barry HIV/AIDS Initiative Amendment Act of 2009”.
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter II - Effi Slaughter Barry HIV/AIDS Initiative › § 7–1614. Designation of an initiative coordinator

§ 7–1614. Designation of an initiative coordinator.
The Director of the Department of Health shall designate an initiative coordinator, who shall be an employee of the Department of Health and qualified by experience and training to administer the initiative.
(Mar. 20, 2008, D.C. Law 17-117, § 5, 55 DCR 1282.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter II - Effi Slaughter Barry HIV/AIDS Initiative › § 7–1615. Participant selection and grant award criteria

§ 7–1615. Participant selection and grant award criteria.
(a) The Department of Health shall establish criteria for:
(1) The selection of community HIV/AIDS service providers to participate in the initiative; and
(2) Awarding grants to initiative participants, including a requirement that the fiduciary agent of any collaborative representing a ward must be located in the ward.
(b) All grants awarded pursuant to the initiative shall be subject to terms and conditions approved by the Department of Health.
(Mar. 20, 2008, D.C. Law 17-117, § 6, 55 DCR 1282; Mar. 3, 2010, D.C. Law 18-111, § 5021(b), 57 DCR 181.)
Effect of Amendments
D.C. Law 18-111 designated the existing text as subsec. (a); and added subsec. (b).
Emergency Legislation
For temporary (90 day) amendment of section, see § 5021(b) of Fiscal Year 2010 Budget Support Second Emergency Act of 2009 (D.C. Act 18-207, October 15, 2009, 56 DCR 8234).
For temporary (90 day) amendment of section, see § 5021(b) of Fiscal Year Budget Support Congressional Review Emergency Amendment Act of 2009 (D.C. Act 18-260, January 4, 2010, 57 DCR 345).
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter II - Effi Slaughter Barry HIV/AIDS Initiative › § 7–1616. Allocation of funding

§ 7–1616. Allocation of funding.
The Department of Health shall distribute capacity building grants to initiative participants in an amount not to exceed the funds available in the Effi Slaughter Barry Initiative Fund, as established by § 7-1617.
(Mar. 20, 2008, D.C. Law 17-117, § 7, 55 DCR 1282; Mar. 3, 2010, D.C. Law 18-111, § 5021(c), 57 DCR 181.)
Effect of Amendments
D.C. Law 18-111 rewrote the section.
Emergency Legislation
For temporary (90 day) amendment of section, see § 5021(c) of Fiscal Year 2010 Budget Support Second Emergency Act of 2009 (D.C. Act 18-207, October 15, 2009, 56 DCR 8234).
For temporary (90 day) amendment of section, see § 5021(c) of Fiscal Year Budget Support Congressional Review Emergency Amendment Act of 2009 (D.C. Act 18-260, January 4, 2010, 57 DCR 345).
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter II - Effi Slaughter Barry HIV/AIDS Initiative › § 7–1617. Effi Slaughter Barry Initiative Fund; establishment, purpose

§ 7–1617. Effi Slaughter Barry Initiative Fund; establishment, purpose.
(a) There is established as a nonlapsing fund the Effi Slaughter Barry Initiative Fund (“Fund”), which shall be a segregated account within the General Fund of the District of Columbia and shall be used solely for the purpose of supporting the initiative.
(b) The Fund shall be administered by the Department of Health.
(c) The Mayor shall deposit into the Fund all general revenue funds appropriated in the budget submitted pursuant to § 1-204.46, and authorized by Congress for the purpose of the initiative.
(d) All funds deposited into the Fund, and any interest earned on those funds, shall not revert to the unrestricted fund balance of the General Fund of the District of Columbia at the end of a fiscal year, or at any other time, but shall be continually available for the uses and purposes set forth in this section without regard to fiscal year limitation, subject to authorization by Congress.
(e) The Director of the Department of Health may make grants from the Fund to effectuate the purpose of the initiative.
(Mar. 20, 2008, D.C. Law 17-117, § 7a; as added Aug. 16, 2008, D.C. Law 17-219, § 5029, 55 DCR 7598; Mar. 3, 2010, D.C. Law 18-111, § 5021(d), 57 DCR 181.)
Section References
This section is referenced in § 7-1616.
Effect of Amendments
D.C. Law 18-111 added subsec. (e).
Emergency Legislation
For temporary (90 day) amendment of section, see § 5021(d) of Fiscal Year 2010 Budget Support Second Emergency Act of 2009 (D.C. Act 18-207, October 15, 2009, 56 DCR 8234).
For temporary (90 day) amendment of section, see § 5021(d) of Fiscal Year Budget Support Congressional Review Emergency Amendment Act of 2009 (D.C. Act 18-260, January 4, 2010, 57 DCR 345).
Short Title
Short title: Section 5028 of D.C. Law 17-219 provided that subtitle L of title V of the act may be cited as the “Effi Slaughter Barry HIV/AIDS Initiative Amendment Act of 2008”.
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter III - Senior HIV/AIDS Education and Outreach Program › § 7–1631. Definitions

§ 7–1631. Definitions.
For the purposes of this subchapter, the term:
(1) “AIDS” means acquired immune deficiency syndrome.
(2) “Department” means the Department of Health.
(3) “HIV” means the human immunodeficiency virus.
(4) “Program” means the Senior HIV/AIDS Education and Outreach Program established by § 7-1632.
(5) “Senior” means an individual 50 years of age or older.
(July 13, 2012, D.C. Law 19-152, § 2, 59 DCR 5136.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter III - Senior HIV/AIDS Education and Outreach Program › § 7–1632. Senior HIV/AIDS Education and Outreach Program establishment

§ 7–1632. Senior HIV/AIDS Education and Outreach Program establishment.
There is established within the Department the Senior HIV/AIDS Education and Outreach Program, which shall train seniors to provide information to other seniors on how to prevent the transmission of HIV and to engage in education and outreach on issues related to HIV and AIDS with community-based providers that serve seniors in the District.
(July 13, 2012, D.C. Law 19-152, § 3, 59 DCR 5136.)
Section References
This section is referenced in § 7-1631.
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16 - AIDS Health Care › Subchapter III - Senior HIV/AIDS Education and Outreach Program › § 7–1633. Program administration

§ 7–1633. Program administration.
(a) The Department shall:
(1) Administer the Program;
(2) Recruit seniors to participate in the Program;
(3) Determine the training curriculum; and
(4) Schedule no fewer than 8 education or community-outreach events annually, which shall be led by seniors who have successfully completed the Program. Each year, at least one event shall be held in each ward.
(b) The Department may contract with a community provider to train the seniors participating in the Program.
(c) Subject to the availability of funds, the Department may provide a stipend to Program participants.
(July 13, 2012, D.C. Law 19-152, § 4, 59 DCR 5136.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16A - Human Papillomavirus Vaccination › § 7–1651.01. Definitions

§ 7–1651.01. Definitions.
For the purposes of this chapter, the term:
(1) “CDC” means the Centers for Disease Control and Prevention.
(2) “HPV” means the human papillomavirus.
(July 12, 2007, D.C. Law 17-10, § 2, 54 DCR 5146.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16A - Human Papillomavirus Vaccination › § 7–1651.02. Human papillomavirus public education campaign

§ 7–1651.02. Human papillomavirus public education campaign.
By January 1, 2008, the Mayor shall initiate a public information campaign, including multiple HPV vaccine education forums in each ward, aimed at educating the public on:
(1) The connection between HPV and cervical cancer;
(2) The importance of protecting oneself against HPV infection;
(3) The value of screening for cervical cancer through regular pap tests; and
(4) The effectiveness and risks of the HPV vaccine.
(July 12, 2007, D.C. Law 17-10, § 3, 54 DCR 5146.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16A - Human Papillomavirus Vaccination › § 7–1651.03. Department of Health certification

§ 7–1651.03. Department of Health certification.
Within 30 days of the implementation of the HPV vaccination program, the Director of the Department of Health shall provide written certification to the Council that the vaccine is safe and efficacious.
(July 12, 2007, D.C. Law 17-10, § 4, 54 DCR 5146.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16A - Human Papillomavirus Vaccination › § 7–1651.04. Human papillomavirus vaccination program

§ 7–1651.04. Human papillomavirus vaccination program.
(a) The Mayor shall:
(1) By January 1, 2009, consistent with the standards set forth by the federal Centers for Disease Control and Prevention (“CDC”), establish and implement a HPV vaccination program that includes a requirement that the Department of Health disseminate to all parents or legal guardians information about HPV, including the benefits and risks of the HPV vaccine;
(2) Require all communications from the Department of Health on the HPV vaccination program to prominently feature information pertaining to the ability of parents or guardians to opt out of the program;
(3) Extend, by rulemaking, the HPV vaccination program requirements to males, consistent with standards set forth by the CDC; and
(4) Require the Department of Health to develop reporting requirements for the collection and analyzation of HPV vaccination data.
(b)(1) By the beginning of the 2009 school year, and of every school year thereafter, the parent or legal guardian of a female child enrolling in grade 6 for the first time at a school in the District of Columbia shall be required to submit certification:
(A) That the child has received the HPV vaccine; or
(B) That the child has not received the HPV vaccine because:
(i) The parent or legal guardian has objected in good faith and in writing to the chief official of the school that the vaccination would violate his or her religious beliefs;
(ii) The child’s private physician, his or her representative, or the public health authority has provided the school written certification that the vaccination is medically inadvisable; or
(iii) The parent or legal guardian, in his or her discretion, has elected to opt out of the HPV vaccination program, for any reason, by signing a form prepared by the Department of Health that states the parent or legal guardian has been informed of the HPV vaccination requirement and has elected not to participate.
(2) The form, provided pursuant to paragraph (1)(B)(iii) of this subsection, shall include the parent or legal guardian’s name, address, and telephone number and the name of the child. The form shall be available in English, Spanish, and any other language that the Mayor considers culturally appropriate.
(July 12, 2007, D.C. Law 17-10, § 5, 54 DCR 5146.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16A - Human Papillomavirus Vaccination › § 7–1651.05. Rules

§ 7–1651.05. Rules.
The Mayor, pursuant to subchapter I of Chapter 5 of Title 2, shall issue rules to implement the provisions of this chapter.
(July 12, 2007, D.C. Law 17-10, § 6, 54 DCR 5146.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16A - Human Papillomavirus Vaccination › § 7–1651.06. Applicability. [Repealed]

§ 7–1651.06. Applicability. [Repealed]
Repealed.
(July 12, 2007, D.C. Law 17-10, § 7, 54 DCR 5146; Aug. 16, 2008, D.C. Law 17-219, § 7089, 55 DCR 7598.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16A-i - Minor Consent to Vaccination › § 7–1653.01. Minor consent to vaccination

§ 7–1653.01. Minor consent to vaccination.
(a) An emancipated minor, a minor who is married or previously has been married, an unaccompanied homeless minor, a minor who is or has been pregnant, or a minor who is separated from their parent or legal guardian for whatever reason and is not supported by their parent or guardian may consent to receive a vaccine recommended by the United States Advisory Committee on Immunization Practices ("ACIP"), and where receipt of the vaccine is in accordance with ACIP's recommended immunization schedule.
(b)(1) A vaccine provider may accept the consent of a minor not otherwise listed in subsection (a) of this section to receive a vaccine recommended by ACIP in accordance with ACIP's recommended immunization schedule; provided, that the vaccine provider reasonably attempts to obtain consent from the minor's parent or legal guardian either in person, in writing, or by telephone, and there is no objection from the parent or legal guardian. Consent of the parent or legal guardian may be assumed if the vaccine provider cannot notify the parent or legal guardian after at least a reasonable attempt to notify has been made.
(2) Nothing in this section prohibits a minor from seeking a court order to authorize receipt of a vaccine by the minor due to the parent's or legal guardian's objection.
(3) This subsection does not require administration of a vaccine if receipt of the vaccine by the minor is medically contraindicated.
(c) For purposes of this section, the term "vaccine provider" means an entity or person authorized to administer the vaccine being sought.
(d) Nothing in this section shall be construed or applied to require or excuse noncompliance with any provision of any federal law.
(Mar. 10, 2023, D.C. Law 24-312, § 2, 70 DCR 598.)
Emergency Legislation
For temporary (90 days) creation of this section, see § 2 of Consent for Vaccinations of Minors Emergency Amendment Act of 2022 (D.C. Act 24-511, July 25, 2022, 69 DCR 009377).
Temporary Legislation
For temporary (225 days) creation of this section, see § 2 of Consent for Vaccinations of Minors Temporary Amendment Act of 2022 (D.C. Law 24-189, Sept. 21, 2022, 69 DCR 009946).
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16B - Use of Marijuana for Medical Treatment › § 7–1671.04. Recommending authorized practitioner; protections

§ 7–1671.04. Recommending authorized practitioner; protections.
(a) A qualifying patient may receive a recommendation from an authorized practitioner to use medical cannabis for a qualifying medical or dental condition or a qualifying medical or dental treatment.
(b) An authorized practitioner may recommend the use of medical cannabis to a qualifying patient, on a form provided by ABCA, if the authorized practitioner makes the recommendation based on an assessment of the qualifying patient's current medical or dental condition.
(c) An authorized practitioner shall not be subject to any penalty, including arrest, prosecution, or disciplinary proceeding, or denial of any right or privilege, for advising a qualifying patient about the use of medical cannabis or recommending the use of medical cannabis to a qualifying patient pursuant to this chapter and any rules issued pursuant to § 7-1671.13.
(d) An authorized practitioner recommending the use of medical cannabis to a qualifying patient shall not have a professional office located at a retailer, internet retailer, cultivation center, manufacturer, or testing laboratory or receive financial compensation from a cultivation center, manufacturer, or testing laboratory, or a director, officer, member, incorporator, agent, or employee of a retailer, internet retailer, cultivation center, courier, manufacturer, or testing laboratory.
(Feb. 25, 2010, D.C. Law 13-315, § 5; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798; Feb. 18, 2017, D.C. Law 21-209, § 2(d), 63 DCR 15291; Dec. 3, 2020, D.C. Law 23-149, § 5012(c), 67 DCR 10493; Mar. 22, 2023, D.C. Law 24-332, § 3(d), 70 DCR 1582.)
Section References
This section is referenced in § 3-1202.03 and § 7-1671.02.
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16B - Use of Marijuana for Medical Treatment › § 7–1671.06b. Unlicensed establishment compliance

§ 7–1671.06b. Unlicensed establishment compliance.
(a) Unlicensed establishments that submit a complete application with ABCA during the 90-calendar day open application period for a cultivation center, retailer, or internet retailer shall not be subject to compliance with this chapter while their retailer or internet retailer application is pending review with the ABC Board; except, that nothing in this subsection shall prohibit ABCA from issuing cease and desist orders to an applicant if the applicant is found to be selling cannabis products that may be especially appealing to children or is using packaging or advertisements that might be especially appealing to children.
(b)(1) A decision by the ABC Board to approve a cultivation center, retailer, or internet retailer license for an unlicensed establishment shall be made in writing at least 15 days prior to the issuance of the license. The notice shall state that the unlicensed establishment shall cease any unlicensed activity immediately.
(2)(A) A decision by the ABC Board to deny an unlicensed establishment's application for a retailer or internet retailer license shall be made in writing to the applicant and shall state the reasons for the denial.
(B)(i) Within 15 days of receipt of the ABC Board's written denial decision, the applicant may submit, in writing, an appeal to the ABC Board to reconsider the denial decision. With the written appeal, the applicant may include any relevant documentation or evidence that contests findings of fact or conclusions of law in the ABC Board's written denial decision.
(ii) If an applicant submits an appeal, the ABC Board shall hold a hearing and render a decision within 30 days.
(C) If the applicant does not appeal the written denial decision, or after the ABC Board renders a decision on an appeal, the ABC Board shall notify the unlicensed establishment that it must close within 30 days after receipt of the denial or be subject to penalties pursuant to § 47-2844(a-2)(1B).
(c) The ABC Board may deny an unlicensed establishment's application for a cultivation center, retailer, or internet retailer license that does not provide the ABC Board with documents necessary to complete the application within 30 days of the ABC Board's request.
(d)(1) An unlicensed establishment that is issued a cultivation center, retailer, or internet retailer license shall be required to open within 120 days of being issued the retailer or internet retailer license.
(2) The ABC Board shall cancel a retailer or internet retailer license issued to an unlicensed establishment that does not open within 120 days.
(Feb. 25, 2010, D.C. Law 13-315, § 7b; as added Mar. 22, 2023, D.C. Law 24-332, § 3(h), 70 DCR 1582.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16B - Use of Marijuana for Medical Treatment › § 7–1671.06d. Education tasting endorsement

§ 7–1671.06d. Education tasting endorsement.
(a)(1)(A) The holder of a retailer license shall be eligible to apply to the ABC Board for an education tasting endorsement.
(B) The holder of an education tasting endorsement shall be permitted to offer cooking and how-to classes and demonstrations, and tastings for educational purposes to qualifying patients and caregivers on-site.
(C) Activities offered by a retailer under an education tasting endorsement shall be permitted to occur on the premises of the retailer; except, that educational activities that include the smoking of medical cannabis by qualifying patients shall occur only in an ABC Board-approved safe-use treatment facility.
(2) The holder of an internet retailer license shall not be eligible for an education tasting endorsement.
(b) A retailer with an education tasting endorsement shall:
(1) Display in the licensed area conspicuous warning labels that are visible to the qualifying patient and the qualifying patient's caregiver concerning the consumption of medical cannabis and medical cannabis products;
(2) Destroy all unconsumed medical cannabis remaining from the educational activity, except as permitted under paragraph (4) of this subsection;
(3) Ensure that containers of medical cannabis to be used for educational activities are labeled as such and may not be sold; and
(4) Be permitted to allow a qualifying patient or caregiver to leave the premises with medical cannabis that was made available or offered as part of the educational activity in accordance with the requirements and limits set forth in this chapter; provided, that it is packaged in accordance with regulations issued pursuant to § 7-1671.13.
(c) A retailer with an education tasting endorsement shall not:
(1) Allow a person to consume alcohol, tobacco, or tobacco products on the premises;
(2) Advertise or promote, in any way, either on or off the premises, a practice prohibited under this section; or
(3) Make unsubstantiated medical claims about cannabis or cannabis products.
(d)(1) Subject to paragraph (2) of this subsection, the holder of an education tasting endorsement may offer educational activities on the licensed premises between the hours of 7:00 a.m. and 9:00 p.m., 7 days per week.
(2) The ABC Board may alter the hours set forth in paragraph (1) of this subsection through rulemaking.
(e) The ABC Board shall establish, by regulation, permitted medical cannabis tasting or consumption limits for educational activities.
(f) An applicant for an education tasting endorsement shall complete an application on a form the ABC Board prescribes by regulations issued pursuant to § 7-1671.13.
(g) The minimum initial application fee for an education tasting endorsement shall be $130. The endorsement shall be valid for 3 years, with a minimum annual fee of $130.
(Feb. 25, 2010, D.C. Law 13-315, § 7d; as added Mar. 22, 2023, D.C. Law 24-332, § 3(h), 70 DCR 1582.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16B - Use of Marijuana for Medical Treatment › § 7–1671.06f. Summer garden endorsement

§ 7–1671.06f. Summer garden endorsement.
(a) The holder of both a retailer license and a safe use treatment facility endorsement shall obtain a summer garden endorsement from the ABC Board to be eligible to conduct operations in a summer garden, which may include the sale, service, and consumption of medical cannabis on outdoor private space.
(b) The holder of a summer garden endorsement may be authorized to conduct business operations in the summer garden only between the hours of 8:00 a.m. and 12:00 a.m., 7 days a week.
(c) The minimum initial application fee for the endorsement shall be $300. The endorsement shall be valid for 3 years with a minimum annual license fee of $300.
(Feb. 25, 2010, D.C. Law 13-315, § 7f; as added Mar. 22, 2023, D.C. Law 24-332, § 3(h), 70 DCR 1582.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16B - Use of Marijuana for Medical Treatment › § 7–1671.07. Health Occupations Boards review of medical marijuana authorized practitioner recommendations. [Repealed]

§ 7–1671.07. Health Occupations Boards review of medical marijuana authorized practitioner recommendations. [Repealed]
Repealed.
(Feb. 25, 2010, D.C. Law 13-315, § 8; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798; Feb. 18, 2017, D.C. Law 21-209, § 2(g), 63 DCR 15291; Dec. 3, 2020, D.C. Law 23-149, § 5012(f), 67 DCR 10493; Mar. 22, 2023, D.C. Law 24-332, § 3(i), 70 DCR 1582.)
Section References
This section is referenced in § 3-1202.03 and § 7-1671.04.
Emergency Legislation
For temporary (90 days) amendment of this section, see § 2(e) of Medical Marijuana Patient Access Extension Second Emergency Amendment Act of 2022 (D.C. Act 24-565, Oct. 17, 2022, 0 DCR 0).
For temporary (90 days) amendment of this section, see § 2(d) of Medical Marijuana Patient Access Extension Congressional Review Emergency Amendment Act of 2022 (D.C. Act 24-400, May 9, 2022, 69 DCR 5035).
For temporary (90 days) amendment of this section, see § 2(d) of Medical Marijuana Patient Access Extension Emergency Amendment Act of 2022 (D.C. Act 24-323, Feb. 11, 2022, 69 DCR 001268).
For temporary (90 days) amendment of this section, see § 2(d) of Medical Marijuana Patient Access Emergency Amendment Act of 2021 (D.C. Act 24-206, Nov. 5, 2021, 68 DCR 012188).
Temporary Legislation
For temporary (225 days) amendment of this section, see § 2(e) of Medical Marijuana Patient Access Extension Second Temporary Amendment Act of 2022 (D.C. Law 24-229, Dec. 21, 2022, 69 DCR 13901).
For temporary (225 days) amendment of this section, see § 2(d) of Medical Marijuana Patient Access Extension Temporary Amendment Act of 2022 (D.C. Law 24-122, May 18, 2022, 69 DCR 002670).
For temporary (225 days) amendment of this section, see § 2(d) of Medical Marijuana Patient Access Temporary Amendment Act of 2021 (D.C. Law 24-78, Feb. 24, 2022, 69 DCR 000204).
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16B - Use of Marijuana for Medical Treatment › § 7–1671.08. Penalties

§ 7–1671.08. Penalties.
(a) Any person who manufactures, cultivates, possesses, administers, dispenses, distributes, or uses cannabis, or manufactures, possesses, distributes, or uses paraphernalia, in a manner not authorized by this chapter or the rules issued pursuant to § 7-1671.13 shall be subject to criminal prosecution and sanction under subchapter I of Chapter 11 of Title 48 [§ 48-1101 et seq.].
(b)(1) Any person who makes a fraudulent representation to a law enforcement official of any fact or circumstance relating to the person's manufacture, cultivation, possession, administration, dispensing, distribution, or use of medical cannabis, or manufacture, possession, distribution, or use of paraphernalia to avoid arrest or prosecution shall be subject to a criminal fine not to exceed $1,000.
[(2)] The imposition of the fine set forth in paragraph (1) of this subsection shall be in addition to any other penalties that may otherwise apply for the making of a false statement or for the manufacture, cultivation, possession, administration, dispensing, distribution, or use of cannabis, or the manufacture, possession, distribution, or use of paraphernalia.
(c) It shall be an affirmative defense to a criminal charge of possession or distribution of cannabis, or possession with intent to distribute cannabis, that the person charged with the offense is a person who:
(1) Was in possession of medical cannabis only inside the qualifying patient’s residence or a medical treatment facility;
(2) Only administered or assisted in administering the medical cannabis to the qualifying patient and only within the qualifying patient’s residence or at a permitted medical treatment facility;
(3) Assisted the qualifying patient only when the caregiver was not reasonably available to provide assistance; and
(4) Is 18 years of age or older.
(d) The ABC Board may impose and adjudicate civil fines for violations of this chapter and rules issued in accordance with § 7-1671.13 committed by licensed cultivation centers, manufacturers, retailers, internet retailers, testing laboratories, and couriers.
(e) Within 180 days after March 22, 2023, the ABC Board shall submit proposed regulations to the Council setting forth a schedule of civil penalties, fines, and fees for violations of this chapter for a 90-day period of review, including Saturdays, Sundays, holidays, and periods of Council recess. If the Council does not approve, in whole or in part, the proposed regulations within the 90-day review period, the regulations shall be deemed approved. The schedule shall replace all civil penalties, except as expressly provided in this chapter.
(Feb. 25, 2010, D.C. Law 13-315, § 9; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798; Mar. 22, 2023, D.C. Law 24-332, § 3(j), 70 DCR 1582.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16B - Use of Marijuana for Medical Treatment › § 7–1671.08a. Medical Cannabis Administration Fund

§ 7–1671.08a. Medical Cannabis Administration Fund.
(a) There is established as a special fund the Medical Cannabis Administration Fund ("Fund"), which shall be administered by ABCA in accordance with subsection (c) of this section.
(b) All funds received from medical cannabis licensing, permitting, and registration fees shall be deposited into the Fund.
(c) Money deposited in the Fund shall be used by ABCA for the purpose of administering the medical cannabis program.
(d)(1) The money deposited into the Fund shall not revert to the unrestricted fund balance of the General Fund of the District of Columbia at the end of a fiscal year, or at any other time.
(2) Subject to authorization in an approved budget and financial plan, any funds appropriated in the Fund shall be continually available without regard to fiscal year limitation.
(e) Funds received from penalties and fines imposed under § 7-1671.08 shall be credited to the unassigned fund balance of the General Fund of the District of Columbia.
(Feb. 25, 2010, D.C. Law 13-315, § 9a; as added Dec. 3, 2020, D.C. Law 23-149, § 5012(g), 67 DCR 10493; Mar. 22, 2023, D.C. Law 24-332, § 3(k), 70 DCR 1582.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16B - Use of Marijuana for Medical Treatment › § 7–1671.08b. Medical Cannabis Social Equity Fund

§ 7–1671.08b. Medical Cannabis Social Equity Fund.
(a) There is established as a special fund the Medical Cannabis Social Equity Fund ("Fund"), which shall be administered by Department of Small and Local Business Development ("DSLBD") in consultation with ABRA and in accordance with subsection (c) of this section.
(b) Revenue from the following sources shall be deposited into the Fund:
(1) All revenue in excess of the amount budgeted in the Fiscal Year 2023 budget for Fiscal Years 2024, 2025, and 2026 collected pursuant to § 47-2002(a)(7);
(2) Beginning October 1, 2026, all revenue collected pursuant to § 47-2002(a)(7);
(3) Any amount above $100,000 in fines imposed and collected pursuant to § 7-1675.01; and
(4) Any amount above $100,000 in fines imposed and collected pursuant to § 47-2844(a-2)(1B).
(c) Money in the Fund shall be used to:
(1) Administer the medical cannabis certified business enterprise program; and
(2) Provide equity, grants, and loans to assist social equity applicants and medical cannabis certified business enterprises in gaining entry to, and successfully operating in, the Program.
(d)(1) The money deposited into the Fund shall not revert to the unrestricted fund balance of the General Fund of the District of Columbia at the end of a fiscal year, or at any other time.
(2) Subject to authorization in an approved budget and financial plan, any funds appropriated in the Fund shall be continually available without regard to fiscal year limitation.
(e) ABRA and DSLBD shall enter into a memorandum of understanding to effectively implement the distribution of funds in the Fund for the purpose set forth in subsection (c) of this section.
(Feb. 25, 2010, D.C. Law 13-315, § 9b; as added Sept. 21, 2022, D.C. Law 24-167, § 5072, 69 DCR 009223; Mar. 22, 2023, D.C. Law 24-332, § 3(l), 70 DCR 1582.)
Emergency Legislation
For temporary (90 days) creation of this section, see § 5072 of Fiscal Year 2023 Budget Support Emergency Act of 2022 (D.C. Act 24-470, July 13, 2022, 69 DCR 008707).
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16B - Use of Marijuana for Medical Treatment › § 7–1671.08c. Equity, grants, and loans to social equity applicants and medical cannabis certified business enterprises. [Not Funded]

§ 7–1671.08c. Equity, grants, and loans to social equity applicants and medical cannabis certified business enterprises. [Not Funded]
Not Funded.
(Feb. 25, 2010, D.C. Law 13-315, § 9c; as added Mar. 22, 2023, D.C. Law 24-332, § 3(m), 70 DCR 1582.)
Applicability
Applicability of D.C. Law 24-332: § 9 of D.C. Law 24-332 provided that the creation of this section by § 3(m) of D.C. Law 24-332 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16B - Use of Marijuana for Medical Treatment › § 7–1671.09. Medical Cannabis Advisory Committee

§ 7–1671.09. Medical Cannabis Advisory Committee.
(a) The Mayor shall establish a Medical Cannabis Advisory Committee (“Committee”), which shall monitor:
(1) Best practices in other states that allow the use of medical cannabis;
(2) Scientific research on the medical use of cannabis; and
(3) The Program's effectiveness.
(b) Repealed.
(Feb. 25, 2010, D.C. Law 13-315, § 10; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798; Mar. 22, 2023, D.C. Law 24-332, § 3(n), 70 DCR 1582.)
2023 District of Columbia Code › Title 7 - Human Health Care and Safety › Chapter 16B - Use of Marijuana for Medical Treatment › § 7–1671.10. Fees

§ 7–1671.10. Fees.
(a) ABCA is authorized to establish, by rulemaking, fees for the licensing of cultivation centers, manufacturers, retailers, internet retailers, couriers, and testing laboratories and for the inspection and audit of cultivation centers, manufacturers, retailers, internet retailers, couriers, and testing laboratories.
(b) Any of the fees collected pursuant to this chapter shall be applied first toward the cost of administering this chapter.
(Feb. 25, 2010, D.C. Law 13-315, § 11; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798; Feb. 18, 2017, D.C. Law 21-209, § 2(h), 63 DCR 15291; Mar. 22, 2023, D.C. Law 24-332, § 3(o), 70 DCR 1582.)